MYDA Advisors’s M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 MBAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-66,350
Closed -$77K 320
2021
Q4
$77K Buy
66,350
+41,350
+165% +$54.8K 0.02% 222
2021
Q3
$34K Buy
+25,000
New +$28K 0.01% 251

Other funds holding MBAC.WS

MYDA Advisors's MBAC.WS Position: Q1 2022 in Review

MYDA Advisors sold out of M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (MBAC.WS) in Q1 2022, closing a stake of 66,350 shares — an estimated $77K sold.

MYDA Advisors first reported a position in MBAC.WS in Q3 2021 and held it in 2 quarters. The position peaked at $77K in Q4 2021. 49 funds tracked by Wall St. Rank hold MBAC.WS as of Q1 2022.

  • MYDA Advisors reported no remaining M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q1 2022 after selling out during the quarter.
  • MYDA Advisors sold 66,350 M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q1 2022, an estimated $77K.
  • MYDA Advisors first reported a position in M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q3 2021 and held it in 2 quarters.
  • MYDA Advisors's M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $77K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q1 2022.

Based on MYDA Advisors's 13F filing for Q1 2022, filed 13 May 2022.